1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TYROBP CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA AIM1L CTRPv2 pan-cancer AAC 0.14 0.0004
mRNA RNASE13 CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA CHST7 CTRPv2 pan-cancer AAC -0.12 0.0004
mRNA RASEF CTRPv2 pan-cancer AAC 0.14 0.0004
mRNA GAPDHS CTRPv2 pan-cancer AAC 0.12 0.0004
mRNA PRR15 CTRPv2 pan-cancer AAC 0.14 0.0004
mRNA KLF5 CTRPv2 pan-cancer AAC 0.16 0.0004
mRNA NEK10 CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA STX6 CTRPv2 pan-cancer AAC 0.13 0.0004
Download CSV